Spanish for eosinophilic esophagitis clinic nurses — the patient who cannot understand why a food-related diagnosis is being made when every allergy test is negative, the patient who cannot understand why an asthma inhaler is prescribed for an esophageal condition and why he must swallow it instead of breathe it in, and the patient who cannot understand why the elimination diet requires removing wheat when the allergy test showed no wheat allergy

Three conversations for eosinophilic esophagitis clinic nurses: a 38-year-old teacher from San Jose diagnosed after food bolus impaction whose husband cannot understand why the gastroenterologist is implicating food when every allergy test came back negative, not knowing EoE is a Th2 eosinophilic inflammation diagnosed by biopsy, not IgE testing; a 52-year-old construction foreman from Dallas prescribed swallowed fluticasone who cannot understand why an asthma inhaler is used for an esophageal condition, not knowing the metered-dose inhaler delivers topical corticosteroid to the esophageal mucosa and swallowing is the deliberate delivery mechanism; and a 29-year-old dental hygienist from Phoenix on the six-food elimination diet who cannot understand why wheat must be removed when her allergy test was negative for wheat, not knowing EoE food triggers are identified by empirical elimination and biopsy response, not by IgE sensitization — each conversation requiring an explanation of why EoE treatment systematically uses interventions the patient associates with completely different conditions.

The EoE clinic nurse’s communication challenge

Eosinophilic esophagitis sits at the intersection of gastroenterology and allergy-immunology in a way that systematically produces the same communication failure. The patient presents with symptoms that feel like a swallowing problem — dysphagia for solids, food getting stuck in the chest, a frightening episode of food bolus impaction that brought them to the emergency department. The gastroenterologist scopes the esophagus and sees rings, furrows, and white exudates; the biopsy returns with a high eosinophil count. The diagnosis is food-driven, the treatment involves eliminating food groups and sometimes taking what looks like an asthma inhaler. But the allergy test is negative. Every single panel. And the treatment — swallowed corticosteroid, eliminated food groups that tested negative on allergy testing — does not map onto any framework the patient recognizes.

This is not an exotic edge-case communication failure. EoE affects roughly 1 in 2,000 people in the United States and its prevalence has been increasing in parallel with atopic disease. A significant fraction of patients with EoE are Latino, and the presenting event — food bolus impaction in a restaurant, a cafeteria, a family dinner — is frightening enough that the family arrives in clinic demanding an explanation, not just a prescription. When the nurse hands a patient a metered-dose corticosteroid inhaler and says “swallow this, do not inhale it,” or places them on a dietary restriction that removes tortillas and bread based on epidemiological data rather than a positive allergy test, the confusion is entirely logical. The EoE clinic nurse’s task is not simply to give instructions but to provide a mechanistic explanation that makes the instructions make sense.

Three conversations that recur with Spanish-speaking patients across the EoE clinic setting:


Scenario 1: Carmen Villanueva — 38, high school Spanish teacher from San Jose, California

Carmen Villanueva has taught high school Spanish for fourteen years. She is careful, articulate, and accustomed to explaining things precisely — which is part of why the last three months have been so frustrating. The episode happened at a faculty dinner: she swallowed a piece of grilled chicken, felt it stop somewhere in her chest, and spent forty-five increasingly alarming minutes unable to swallow even her own saliva before her husband Marcos drove her to the emergency department. The endoscopy that removed the food bolus also revealed what the gastroenterologist described as “a classic EoE appearance”: concentric rings throughout the esophagus, linear furrows in the mucosa, and scattered white plaques of eosinophil aggregates. The biopsy confirmed it — thirty-two eosinophils per high-power field in the mid-esophagus, well above the diagnostic threshold of fifteen.

The gastroenterologist referred Carmen and Marcos to the EoE clinic. Marcos, who sat through the emergency department visit gripping Carmen’s hand and watching a GI fellow manipulate an endoscope past a piece of chicken lodged in his wife’s chest, arrived at the clinic appointment with a single question he had been turning over for three weeks: “Le mandaron las pruebas de alergía. Todo salió negativo. Trigo, lácteos, huevo, maní, árbol de nueces, mariscos. Todo negativo. Y ahora el médico dice que es una enfermedad causada por alimentos. ¿Cómo puede ser una enfermedad de alimentos si todas las pruebas de alergia salieron negativas?” (They sent her for allergy tests. Everything came back negative. Wheat, dairy, egg, peanut, tree nuts, shellfish. All negative. And now the doctor says it is a food-caused disease. How can it be a food disease if all the allergy tests came back negative?)

EoE clinic nurse Adriana Solano-Reyes had heard this question hundreds of times in nearly a decade of EoE nursing. She knew that the answer required explaining two parallel immune mechanisms — how IgE-mediated allergy works, and how EoE works — so that Marcos could understand why both could be true simultaneously: every allergy test negative, every food panel negative, and food still driving the disease.

“Tiene toda la razón en que eso parece contradictorio,” she said. “Y la respuesta requiere entender por qué la prueba de alergia mide una cosa, y la EoE es una cosa diferente.” (You are completely right that this seems contradictory. And the answer requires understanding why the allergy test measures one thing, and EoE is a different thing.)

She explained IgE-mediated food allergy from the ground up. In a classic food allergy — peanut, shellfish — the immune system generates allergen-specific IgE antibodies during an initial sensitization event. These IgE antibodies bind to receptors on the surface of mast cells throughout the body and sit there, primed. When the person eats the food again, the allergen enters the bloodstream and encounters mast cells bearing its IgE. The IgE-allergen binding cross-links the receptor complexes and triggers immediate mast cell degranulation — histamine, tryptase, prostaglandins flood the surrounding tissue within minutes. The result is the familiar immediate allergic reaction: urticaria, angioedema, vomiting, and at severe levels, hypotension and cardiovascular collapse. Fast. Dramatic. IgE-driven.

“La prueba de alergia — la prueba de piel y el análisis de sangre — mide exactamente eso: si hay anticuerpos IgE contra un alimento específico,” Adriana said. “Si los hay, la prueba es positiva. Si no los hay, es negativa. En el caso de Carmen, las pruebas son negativas porque no hay anticuerpos IgE contra ninguno de esos alimentos. Eso es correcto. La prueba está haciendo bien su trabajo.” (The allergy test — the skin test and the blood analysis — measures exactly that: whether there are IgE antibodies against a specific food. If there are, the test is positive. If there are not, it is negative. In Carmen’s case, the tests are negative because there are no IgE antibodies against any of those foods. That is correct. The test is doing its job well.)

She paused, then continued. “La esofagitis eosinofílica funciona a través de un mecanismo completamente diferente. No es una reacción IgE. Es una inflamación crónica de la pared del esófago causada por un tipo de célula inmune llamado eosinófilo. Normalmente, el esófago tiene muy pocos eosinófilos — es una de las pocas partes del tracto digestivo donde prácticamente no debería haberlos. En la EoE, proteínas de ciertos alimentos llegan al esófago y activan una respuesta inmune que recluta eosinófilos hacia la pared del esófago. Se acumulan, producen inflamación, y con el tiempo, cicatrización. Eso es lo que produce los aníllos que se ven en la endoscopia — tejido cicatricial, fibrosis, un esófago que se va estrechando y poniendo rígido. Ese mecanismo no genera anticuerpos IgE. Por eso la prueba de alergia sale negativa: porque no está midiendo el mecanismo que tiene Carmen.” (Eosinophilic esophagitis works through a completely different mechanism. It is not an IgE reaction. It is a chronic inflammation of the esophageal wall caused by a type of immune cell called an eosinophil. Normally, the esophagus has very few eosinophils — it is one of the few parts of the digestive tract where there should practically be none. In EoE, proteins from certain foods reach the esophagus and activate an immune response that recruits eosinophils into the esophageal wall. They accumulate, produce inflammation, and over time, scarring. That is what produces the rings seen on endoscopy — scar tissue, fibrosis, an esophagus that gradually narrows and stiffens. That mechanism does not generate IgE antibodies. That is why the allergy test comes back negative: because it is not measuring the mechanism that Carmen has.)

Marcos absorbed this. “¿O sea que los dos pueden estar pasando al mismo tiempo? ¿Podría tener una alergia al maní Y la EoE al mismo tiempo?” (So both can be happening at the same time? She could have a peanut allergy AND EoE at the same time?)

“Sí,” Adriana said. “Son mecanismos paralelos e independientes. Una persona puede tener EoE sin ninguna alergia IgE. Puede tener alergias IgE sin EoE. O puede tener ambas — son enfermedades diferentes que comparten algunos factores de riesgo atópicos. En el caso de Carmen, las pruebas dicen que no hay alergias IgE en este momento. La EoE la tiene. Son dos preguntas diferentes, y la prueba de alergia solo responde una de ellas.” (Yes. They are parallel and independent mechanisms. A person can have EoE without any IgE allergy. Can have IgE allergies without EoE. Or can have both — they are different diseases that share some atopic risk factors. In Carmen’s case, the tests say there are no IgE allergies at this time. She does have EoE. They are two different questions, and the allergy test only answers one of them.)

Carmen looked at the endoscopy photos she had been carrying around for three weeks. “Entonces el diagnóstico es la biopsia, no la prueba de alergia.” (So the diagnosis is the biopsy, not the allergy test.)

“Exactamente. La EoE se diagnostica contando los eosinófilos en la biopsia del esófago. No hay ninguna prueba de sangre ni de piel que lo diagnostique. El estándar es quince eosinófilos o más por campo de alta potencia en la biopsia esofágica. Carmen tenía treinta y dos. Es un diagnóstico sólido.” (Exactly. EoE is diagnosed by counting eosinophils in the esophageal biopsy. There is no blood test or skin test that diagnoses it. The standard is fifteen or more eosinophils per high-power field in the esophageal biopsy. Carmen had thirty-two. It is a solid diagnosis.)


Scenario 2: Roberto Ochoa — 52, construction foreman from Dallas, Texas

Roberto Ochoa has run construction crews in the Dallas metro for twenty-two years. He is not a man who complains about discomfort — a fact he mentioned to the gastroenterologist when describing the years of food sticking, the modification of his eating habits (cutting everything small, chewing until something approaching paste), and the single explicit episode of impaction that finally brought him in. The endoscopy showed classic EoE. The biopsy confirmed it. He was started on the six-food elimination diet and referred to the EoE clinic.

At his first clinic visit, he was given a prescription for fluticasone propionate metered-dose inhaler — the standard 44 mcg per actuation formulation. He held it for a moment. “Esto es el inhalador de mi esposa,” he said. “Para el asma. Yo no tengo asma. Y si lo uso para el esófago, ¿por qué no me dan una pastilla? ¿Por qué un inhalador?” (This is my wife’s inhaler. For asthma. I do not have asthma. And if it is for the esophagus, why not give me a pill? Why an inhaler?)

EoE clinic nurse Rosa Camacho-Vega appreciated the precision of the question. Roberto was not resistant — he was an engineer at heart, someone who needed to understand the mechanism before he would trust the instruction.

“La razón es topográfica,” she said. “La inflamación de la EoE está en la superficie interna del esófago — la mucosa. El objetivo del tratamiento es poner el esteroide directamente en contacto con esa mucosa, como un ungüento sobre una llaga. Si tomara una pastilla oral de esteroide — como la prednisona — el esteroide se absorbería en el intestino, pasaría por el hígado, y llegaría al esófago a través de la sangre. Eso funciona, pero con efectos secundarios sistémicos a largo plazo — aumento de peso, el hueso se debilita, la glándula suprarrenal se suprime. No es sostenible para una enfermedad crónica.” (The reason is topographic. The inflammation of EoE is on the inner surface of the esophagus — the mucosa. The goal of the treatment is to put the steroid directly in contact with that mucosa, like an ointment on a sore. If you took an oral steroid pill — like prednisone — the steroid would be absorbed in the intestine, pass through the liver, and reach the esophagus through the blood. That works, but with long-term systemic side effects — weight gain, weakened bone, suppressed adrenal gland. It is not sustainable for a chronic disease.)

“¿Y el inhalador llega al esófago?” Roberto asked. (And the inhaler reaches the esophagus?)

“Cuando se usa de la manera que se lo explico — sí. La clave es cómo lo usa. Si lo inhala como para el asma, el esteroide llega a los pulmones — que es exactamente donde no lo necesita. Si lo activa en la boca y lo traga — sin respirar profundo — el esteroide se deposita en la faringe y en la mucosa del esófago mientras baja. Eso es lo que queremos. El esófago absorbe el esteroide localmente, suprime la inflamación eosinofílica en el sitio, y la cantidad que llega a la sangre es muy pequeña porque la fluticasona se inactiva casi por completo en el primer paso por el hígado.” (When used the way I am going to explain — yes. The key is how you use it. If you inhale it like you would for asthma, the steroid reaches the lungs — which is exactly where you do not need it. If you actuate it into the mouth and swallow it — without breathing in deeply — the steroid deposits on the pharynx and on the esophageal mucosa as it travels down. That is what we want. The esophagus absorbs the steroid locally, suppresses the eosinophilic inflammation at the site, and the amount that reaches the bloodstream is very small because fluticasone is almost completely inactivated on the first pass through the liver.)

Roberto turned the inhaler over in his hands. “¿Y los treinta minutos sin comer?” (And the thirty minutes without eating?)

“Imagínese que aplica un ungüento en una herida y de inmediato se lava con agua. El medicamento se va antes de que se absorba. Lo mismo pasa aquí: si come o bebe de inmediato después de tragar el inhalador, el esteroide que se depositó en la mucosa del esófago se arrastra con el bolo alimenticio y desaparece. Los treinta minutos le dan tiempo al tejido para absorber el medicamento. Ese tiempo de contacto es parte del mecanismo.” (Imagine you apply an ointment to a wound and immediately wash it with water. The medication leaves before it is absorbed. The same thing happens here: if you eat or drink immediately after swallowing the inhaler, the steroid that deposited on the esophageal mucosa gets swept away with the food bolus and disappears. The thirty minutes give the tissue time to absorb the medication. That contact time is part of the mechanism.)

Roberto nodded. “Eso tiene sentido. El inhalador no es para el pecho. Es para el esófago.” (That makes sense. The inhaler is not for the chest. It is for the esophagus.)

“Exactamente. El inhalador es el vehículo de entrega. El pulmón no es el destino — el esófago es el destino.” (Exactly. The inhaler is the delivery vehicle. The lung is not the destination — the esophagus is the destination.)

Rosa added one practical clarification before they finished: unlike asthma inhalers, which require a spacer to optimize pulmonary delivery, swallowed fluticasone should be used without a spacer, and he should not rinse his mouth with water immediately after because rinsing could carry steroid back down the esophagus inconsistently or alter the deposition pattern. He should actuate two puffs, swallow each, and then wait the thirty minutes. If he developed oral candidiasis — a white coating in the mouth, which can occasionally occur — he should report it at his next visit. “Es raro con la dosis que le damos para EoE, pero si ve manchas blancas en la boca, díganos.” (It is uncommon with the dose we give for EoE, but if you see white patches in the mouth, tell us.)


Scenario 3: Luisa Hernández-Ramos — 29, dental hygienist from Phoenix, Arizona

Luisa Hernández-Ramos graduated from dental hygiene school four years ago and has been working in a pediatric dental office on the west side of Phoenix since. She is careful and methodical — habits she attributes to the attention to detail that dental hygiene requires — and when she was diagnosed with EoE after a referral for progressive dysphagia, she went home and read everything she could find before her EoE clinic appointment. Which is why she arrived with a specific objection, printed research in hand.

“Me pusieron la dieta de eliminación de seis alimentos,” she said, placing the printout on the desk. “Lácteos, trigo, huevo, soya, nueces, mariscos. Entiendo los lácteos — la literatura dice que son el detonante más común. Entiendo los mariscos. Pero el trigo — la prueba de alergia al trigo salió negativa. He comido tortillas y pan toda mi vida. No hay una comida específica que identifique como detonante. ¿Por qué tengo que eliminar el trigo si la prueba dice que no soy alérgica al trigo?” (They put me on the six-food elimination diet. Dairy, wheat, egg, soy, nuts, shellfish. I understand dairy — the literature says they are the most common trigger. I understand shellfish. But wheat — the wheat allergy test came back negative. I have eaten tortillas and bread my whole life. There is no specific food I identify as a trigger. Why do I have to eliminate wheat if the test says I am not allergic to wheat?)

EoE clinic nurse Daniela Herrera-Santos recognized immediately that Luisa had done her homework. She had read the right literature and identified the right contradiction. This was not a patient who needed to be reassured — she needed a complete and accurate explanation of why the allergy test and the elimination diet operate on different principles.

“Usted leyó bien,” Daniela said. “Y la tensión que identificó es real. La razón por la que la dieta incluye el trigo aunque la prueba de alergia sea negativa es que la dieta no está basada en pruebas de alergia. Está basada en datos epidemiológicos de pacientes con EoE.” (You read correctly. And the tension you identified is real. The reason the diet includes wheat even though the allergy test is negative is that the diet is not based on allergy tests. It is based on epidemiological data from EoE patients.)

She explained the origin of the six-food elimination diet. The SFED was developed through systematic clinical research: gastroenterologists treated EoE patients with total elemental diet (an amino-acid-based formula that eliminates all intact food proteins and consistently induces histologic remission in EoE) and then reintroduced food groups one at a time while monitoring for relapse by biopsy. Across multiple cohorts of adult and pediatric EoE patients, the food groups that most frequently triggered histologic relapse after reintroduction were dairy proteins, wheat gluten, egg proteins, and soy, followed by tree nuts and seafood. The six-food elimination diet eliminates these six groups together as the starting point — not because every patient reacts to all six, but because they represent the highest-yield elimination approach before the patient-specific reintroduction identifies which ones individually trigger their EoE.

“¿Y por qué la prueba de alergia no puede decir cuáles son los detonantes de la EoE específicamente?” Luisa asked. (And why can the allergy test not say which are the specific EoE triggers?)

“Porque el mecanismo por el que el trigo — o cualquier otro alimento — produce inflamación en la EoE no es el mismo mecanismo que la prueba de alergia mide. La prueba de alergia mide la respuesta IgE: anticuerpos específicos generados por el sistema inmune contra proteínas alimentarias específicas. En la alergia clásica al trigo, hay IgE anti-gliadina o anti-gluten circulando. En la EoE, el trigo puede producir inflamación eosinofílica en el esófago a través de un mecanismo de células T — una respuesta inmune adaptativa que no genera IgE. Los dos mecanismos son paralelos e independientes. La prueba de alergia mide uno y no dice nada sobre el otro. Si la prueba al trigo es negativa, significa que no hay IgE anti-trigo — lo cual es completamente compatible con que el trigo esté produciendo su EoE a través de la vía T-linfocitaria.” (Because the mechanism by which wheat — or any other food — produces inflammation in EoE is not the same mechanism that the allergy test measures. The allergy test measures the IgE response: specific antibodies generated by the immune system against specific food proteins. In classic wheat allergy, there is anti-gliadin or anti-gluten IgE circulating. In EoE, wheat can produce eosinophilic inflammation in the esophagus through a T-cell mechanism — an adaptive immune response that does not generate IgE. The two mechanisms are parallel and independent. The allergy test measures one and says nothing about the other. If the wheat test is negative, it means there is no anti-wheat IgE — which is completely compatible with wheat producing your EoE through the T-lymphocyte pathway.)

Luisa looked at her printed papers. “¿Y después de la eliminación, cómo sé cuál es mi detonante?” (And after the elimination, how do I know which one is my trigger?)

“Ahí es donde entra la reintroducción secuencial. Primero eliminamos los seis alimentos juntos y esperamos seis a ocho semanas. Luego hacemos una endoscopia con biopsia para verificar si la inflamación bajó. Si la biopsia muestra remisión — menos de quince eosinófilos por campo — sabemos que uno de esos seis alimentos es el responsable. Luego reintroducimos un grupo a la vez — normalmente empezando por los menos comunes, como mariscos y nueces — y después de seis semanas de cada reintroducción, hacemos otra biopsia. Si la biopsia sigue limpia, ese alimento no es su detonante y puede comerlo. Si la biopsia muestra recaída, eso confirma que ese alimento está produciendo su EoE. Lo eliminamos permanentemente y seguimos con el siguiente grupo.” (That is where sequential reintroduction comes in. First we eliminate all six foods together and wait six to eight weeks. Then we do an endoscopy with biopsy to verify whether the inflammation decreased. If the biopsy shows remission — fewer than fifteen eosinophils per field — we know one of those six foods is responsible. Then we reintroduce one group at a time — usually starting with the least common ones, like shellfish and tree nuts — and after six weeks of each reintroduction, we do another biopsy. If the biopsy stays clean, that food is not your trigger and you can eat it. If the biopsy shows relapse, that confirms that food is producing your EoE. We eliminate it permanently and continue with the next group.)

Luisa set down her papers. “O sea, el punto no es eliminar todo para siempre. El punto es usar la eliminación como herramienta de diagnóstico.” (So the point is not to eliminate everything forever. The point is to use the elimination as a diagnostic tool.)

“Exactamente,” Daniela said. “La dieta de eliminación es la prueba de alergias de la EoE. No la prueba de alergia de la clínica de alergia — porque esa mide el IgE y la EoE no es IgE. La 'prueba de alergia' para la EoE es: eliminar, biopsiar, reintroducir uno por uno, biopsiar otra vez. Ese proceso le va a decir a qué alimento específico reacciona su esófago, con una precisión que ninguna prueba de sangre puede dar en esta enfermedad.” (Exactly. The elimination diet is the allergy test for EoE. Not the allergy test from the allergy clinic — because that measures IgE and EoE is not IgE. The ‘allergy test’ for EoE is: eliminate, biopsy, reintroduce one by one, biopsy again. That process will tell you which specific food your esophagus reacts to, with a precision that no blood test can provide for this disease.)

She mentioned one practical note on wheat specifically: wheat is the second most common EoE trigger in US adults after dairy, and it is present in a wide range of foods that patients may not immediately think of — soy sauce, some seasonings, mole base, flour tortillas, pasta, beer. She gave Luisa a wallet card with a list of common wheat-containing foods in both English and Spanish. “No le pongo esa lista para asustarla — se la pongo porque la eliminación del trigo solo es informativa si es completa. Un poco de trigo oculto en la salsa puede producir suficiente inflamación como para confundir la biopsia.” (I am not giving you that list to frighten you — I am giving it to you because wheat elimination is only informative if it is complete. A little hidden wheat in the sauce can produce enough inflammation to confuse the biopsy.)


Eight practical phrases for EoE clinic nurses

  1. Explaining why EoE allergy tests are negative despite food involvement: “La EoE es causada por alimentos, pero no a través del mismo mecanismo que la alergia clásica. La prueba de alergia mide anticuerpos IgE contra alimentos específicos. La EoE funciona a través de un mecanismo de células T que no genera IgE. Por eso la prueba sale negativa: está midiendo el mecanismo de la alergia clásica, que no es el mecanismo de la EoE.” (EoE is caused by foods, but not through the same mechanism as classic allergy. The allergy test measures IgE antibodies against specific foods. EoE works through a T-cell mechanism that does not generate IgE. That is why the test comes back negative: it is measuring the mechanism of classic allergy, which is not the mechanism of EoE.)
  2. Explaining the EoE diagnostic standard: “El diagnóstico de la EoE se hace con biopsia del esófago — quince o más eosinófilos por campo en el tejido del esófago. No hay prueba de sangre ni de piel que la diagnostique. La biopsia es el estándar.” (The EoE diagnosis is made with an esophageal biopsy — fifteen or more eosinophils per field in the esophageal tissue. There is no blood test or skin test that diagnoses it. The biopsy is the standard.)
  3. Explaining how to take swallowed fluticasone correctly: “Active el inhalador dentro de la boca y tráguelo — no lo inhale. No use espaciador. No coma ni beba nada durante treinta minutos. El medicamento tiene que quedar en contacto con la pared del esófago el mayor tiempo posible para que se absorba.” (Actuate the inhaler inside the mouth and swallow it — do not inhale it. Do not use a spacer. Do not eat or drink anything for thirty minutes. The medication needs to remain in contact with the esophageal wall for as long as possible to be absorbed.)
  4. Explaining why topical corticosteroid is preferred over oral prednisone: “La prednisona oral funciona pero tiene efectos secundarios sistémicos a largo plazo — peso, hueso, suprarrenal. El esteroide tópico tragado actúa directamente en el esófago con mínima absorción sistémica. Para una enfermedad crónica que necesita tratamiento continuo, la vía tópica es sostenible. La prednisona no lo es.” (Oral prednisone works but has long-term systemic side effects — weight, bone, adrenal. The swallowed topical steroid acts directly in the esophagus with minimal systemic absorption. For a chronic disease that requires ongoing treatment, the topical route is sustainable. Prednisone is not.)
  5. Explaining why the six-food elimination diet is not based on allergy tests: “Los seis alimentos se eliminan porque son los más frecuentes en la EoE en estudios de cientos de pacientes — no porque la prueba de alergia los señaló. La prueba de alergia no puede identificar detonantes de la EoE porque el mecanismo no es IgE.” (The six foods are eliminated because they are the most common in EoE in studies of hundreds of patients — not because the allergy test identified them. The allergy test cannot identify EoE triggers because the mechanism is not IgE.)
  6. Explaining the biopsy-driven reintroduction protocol: “Después de la eliminación, reintroducimos un grupo de alimentos a la vez y hacemos una biopsia después de cada uno. La biopsia es la que nos dice si ese alimento activó la EoE o no. Ese proceso identifica cuál es su detonante específico. La dieta de eliminación no es el tratamiento permanente — es la herramienta para encontrar el detonante.” (After the elimination, we reintroduce one food group at a time and do a biopsy after each one. The biopsy is what tells us whether that food activated EoE or not. That process identifies your specific trigger. The elimination diet is not the permanent treatment — it is the tool to find the trigger.)
  7. Explaining the risk of untreated EoE after food bolus impaction: “El atascamiento ocurrió porque la inflamación crónica estrechó el esófago. Sin tratamiento, la inflamación continúa, la cicatrización avanza, el esófago se estrecha más, y el riesgo de que vuelva a pasar aumenta. La dilatación abrió el esófago mecánicamente pero no trató la inflamación. El tratamiento médico es el siguiente paso.” (The impaction occurred because chronic inflammation narrowed the esophagus. Without treatment, the inflammation continues, the scarring progresses, the esophagus narrows further, and the risk of it happening again increases. The dilation opened the esophagus mechanically but did not treat the inflammation. Medical treatment is the next step.)
  8. Explaining why endoscopic surveillance is needed even when symptoms improve: “Los síntomas mejoran cuando la inflamación baja — pero algunos pacientes con muchos eosinófilos en la biopsia se sienten relativamente bien. Los síntomas y la biopsia no siempre concuerdan. Las endoscopias de seguimiento son para monitorear la inflamación real, no solo cómo se siente. Un esófago que parece mejor puede seguir cicatrizándose silenciosamente.” (Symptoms improve when inflammation decreases — but some patients with many eosinophils on biopsy feel relatively well. Symptoms and biopsy do not always agree. Follow-up endoscopies are to monitor the actual inflammation, not just how the patient feels. An esophagus that seems better may still be silently scarring.)

FAQs: eosinophilic esophagitis, Spanish-speaking patients, and EoE nursing communication

How do eosinophilic esophagitis clinic nurses explain to a Spanish-speaking patient why the allergy tests are negative but food is still causing the esophageal disease?

EoE allergy tests are negative because EoE is not IgE-mediated. Allergy skin-prick tests and serum specific IgE panels measure IgE antibodies against food allergens — the mechanism of classic immediate hypersensitivity. EoE is driven by a Th2-polarized T-cell response to food antigens that recruits eosinophils into the esophageal epithelium through an IgE-independent mechanism involving IL-5, IL-13, and eotaxin-3. No IgE is generated, so the allergy test correctly returns negative. The EoE diagnosis requires endoscopic biopsy of the esophagus showing fifteen or more eosinophils per high-power field — not allergy testing. The key Spanish frame: “La prueba de alergia mide el mecanismo de la alergia clásica. La EoE funciona a través de un mecanismo diferente que no genera IgE. Por eso la prueba es negativa: está midiendo lo que no tiene usted. El diagnóstico de la EoE es la biopsia del esófago, no la prueba de alergia.”

How do EoE clinic nurses explain why a swallowed corticosteroid inhaler treats an esophageal condition?

Swallowed fluticasone or budesonide delivers topically active corticosteroid to the esophageal mucosa, the site of eosinophilic inflammation, without significant systemic absorption. The inhaler is actuated into the mouth and swallowed (without inhaling) to deposit steroid on the esophageal lining. Fluticasone is inactivated by first-pass hepatic metabolism; budesonide oral viscous suspension is formulated to maximize esophageal mucosal contact time. Oral prednisone is effective but produces systemic side effects that make it unsuitable for chronic maintenance. Patients should not eat or drink for thirty minutes after the dose to prevent washout. The key Spanish frame: “El inhalador se traga, no se inhala, para que el esteroide llegue directamente a la pared del esófago. Si lo inhalara, llegaría a los pulmones donde no lo necesita. No coma ni beba durante treinta minutos para que el medicamento se absorba en el esófago antes de que se lave.”

How do EoE clinic nurses explain why the six-food elimination diet removes wheat when the allergy test was negative for wheat?

The six-food elimination diet (dairy, wheat, eggs, soy, tree nuts, seafood and shellfish) was derived from epidemiological data showing which foods most commonly trigger EoE relapse on reintroduction across large patient cohorts — not from IgE allergy testing. EoE food sensitivity is non-IgE-mediated; allergy testing cannot identify EoE triggers. Wheat is the second most common EoE trigger in US adults after dairy. A negative wheat allergy test is fully compatible with wheat-driven EoE through a Th2 T-cell mechanism. The elimination-reintroduction protocol with sequential biopsy after each reintroduction identifies the patient-specific triggers. The key Spanish frame: “La dieta elimina el trigo aunque la prueba sea negativa porque la EoE no funciona a través del IgE que la prueba mide. El trigo es un detonante frecuente en la EoE en estudios de pacientes. La única forma de saber si es su detonante específico es eliminarlo y reintroducirlo con biopsia.”

How do EoE clinic nurses explain what causes food bolus impaction and why endoscopic dilation does not replace medical therapy?

Food bolus impaction in EoE results from progressive esophageal fibrosis and stricturing caused by chronic eosinophilic inflammation — the esophagus develops concentric rings, loss of distensibility, and reduced luminal diameter. Endoscopic dilation mechanically opens the narrowed lumen and provides symptom relief but does not treat the underlying eosinophilic inflammation, which continues to drive ongoing fibrosis. Without anti-inflammatory treatment (dietary therapy, topical corticosteroids, or both), the esophagus progressively narrows and impaction risk increases. The key Spanish frame: “La dilatación abrió el esófago mecánicamente pero no trató la inflamación que está produciendo el estrechamiento. Sin tratamiento, la inflamación continúa y el esófago se sigue estrechando. El tratamiento médico trata la causa, no solo la consecuencia.”

What are the key Spanish phrases EoE clinic nurses use when explaining the diagnosis, dietary therapy, and swallowed corticosteroid instructions to Spanish-speaking patients?

EoE clinic nurses encounter four recurring communication moments. When explaining why the allergy test is negative despite food-driven disease: “La EoE es causada por alimentos, pero a través de un mecanismo que no genera anticuerpos IgE. La prueba de alergia mide el IgE. La EoE no usa ese mecanismo. Por eso la prueba sale negativa — y por eso el diagnóstico es la biopsia del esófago, no la prueba de alergia.” When explaining swallowed corticosteroid use: “Actívelo en la boca y tráguelo — no lo inhale. No coma ni beba durante treinta minutos. El objetivo es que el esteroide llegue a la pared del esófago y se absorba localmente donde está la inflamación.” When explaining the six-food elimination diet logic: “Los seis alimentos se eliminan porque son los más frecuentes en la EoE — no porque la prueba de alergia los identificó. Después de la eliminación, reintroducimos uno por uno con biopsia para identificar cuál es su detonante específico.” When explaining the need for endoscopic surveillance: “Los síntomas y la biopsia no siempre concuerdan en la EoE. Seguimos haciendo endoscopias para ver la inflamación real, no solo cómo se siente. Un esófago que parece bien puede seguir cicatrizándose si la inflamación no está completamente controlada.”